EGI
MLAB icon

EAM Global Investors’s Mesa Laboratories MLAB Stock Holding History

EAM Global Investors’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,052
Closed -$2.31M – 257
2021
Q4 		$2.31M Hold
7,052
– – 0.41% 130
2021
Q3 		$2.13M Buy
+7,052
New +$2M 0.5% 88

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

EAM Global Investors's MLAB Position: Q1 2022 in Review

EAM Global Investors sold out of Mesa Laboratories (MLAB) in Q1 2022, closing a stake of 7,052 shares — an estimated $2.31M sold.

EAM Global Investors first reported a position in MLAB in Q3 2021 and held it in 2 quarters. The position peaked at $2.31M in Q4 2021. 175 funds tracked by Wall St. Rank hold MLAB as of Q1 2022.

  • EAM Global Investors reported no remaining Mesa Laboratories position as of Q1 2022 after selling out during the quarter.
  • EAM Global Investors sold 7,052 Mesa Laboratories shares in Q1 2022, an estimated $2.31M.
  • EAM Global Investors first reported a position in Mesa Laboratories in Q3 2021 and held it in 2 quarters.
  • EAM Global Investors's Mesa Laboratories position peaked at $2.31M in Q4 2021.
  • 175 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2022.

Based on EAM Global Investors's 13F filing for Q1 2022, filed 13 May 2022.